Document is current
Any future updates will be listed below
-
Authors
Yasuda, Takeshi
Takagi, Tomohisa
Asaeda, Kohei
Hashimoto, Hikaru
Kajiwara, Mariko
Azuma, Yuka
Kitae, Hiroaki
Hirai, Yasuko
Mizushima, Katsura
Doi, Toshifumi
Inoue, Ken
Dohi, Osamu
Yoshida, Naohisa
Uchiyama, Kazuhiko
Ishikawa, Takeshi
Konishi, Hideyuki
Ukawa, Yuichi
Kohara, Akiko
Kudoh, Masatake
Inoue, Ryo
Naito, Yuji
Itoh, Yoshito
-
Funding
Funding for this research was provided by:
Mitsubishi Tanabe Pharma Corporation
PreMedica, Inc.
EA Pharma Co., Ltd.
Taiyo Kagaku Co., Ltd.
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 24 June 2024
First Online: 8 July 2024
Competing interests
: Tomohisa Takagi received collaborative research funds from Mitsubishi Tanabe Pharma Corporation and PreMedica, Inc.; and lecture fees from Mochida Pharma Co., Ltd., Janssen Pharmaceutical K.K., and Mitsubishi Tanabe Co., Ltd. Yuji Naito received scholarship funds from EA Pharma Co., Ltd.; a collaboration research fund from Taiyo Kagaku Co., Ltd.; and lecture fees from Mylan EPD Co., Takeda Pharma Co., Ltd., Mochida Pharma Co., Ltd., EA Pharma Co., Ltd., Otsuka Pharma, Co., Ltd., and Miyarisan Pharma. These funding sources partially supported this study. Yoshito Itoh received a lecture fee from the AbbVie GK research fund of AbbVie GK (Takeda Pharma) Co., Ltd. and EA Pharma Co. Ltd. Kazuhiko Uchiyama received a lecture fee from Mitsubishi Tanabe Pharma Corporation.
